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Abstract
Vertebrate development requires progressive commitment of embryonic cells into specific lineages through a continuum of
signals that play off differentiation versus multipotency. In mammals, Nanog is a key transcription factor that maintains
cellular pluripotency by controlling competence to respond to differentiation cues. Nanog orthologs are known in most
vertebrates examined to date, but absent from the Anuran amphibian Xenopus. Interestingly, in silico analyses and literature
scanning reveal that basal vertebrate ventral homeobox (ventxs) and mammalian Nanog factors share extensive structural,
evolutionary and functional properties. Here, we reassess the role of ventx activity in Xenopus laevis embryos and
demonstrate that they play an unanticipated role as guardians of high developmental potential during early development.
Joint over-expression of Xenopus ventx1.2 and ventx2.1-b (ventx1/2) counteracts lineage commitment towards both dorsal
and ventral fates and prevents msx1-induced ventralization. Furthermore, ventx1/2 inactivation leads to down-regulation of
the multipotency marker oct91 and to premature differentiation of blastula cells. Finally, supporting the key role of ventx1/2
in the control of developmental potential during development, mouse Nanog (mNanog) expression specifically rescues
embryonic axis formation in ventx1/2 deficient embryos. We conclude that during Xenopus development ventx1/2 activity,
reminiscent of that of Nanog in mammalian embryos, controls the switch of early embryonic cells from uncommitted to
committed states.
Citation: Scerbo P, Girardot F, Vivien C, Markov GV, Luxardi G, et al. (2012) Ventx Factors Function as Nanog-Like Guardians of Developmental Potential in
Xenopus. PLoS ONE 7(5): e36855. doi:10.1371/journal.pone.0036855
Editor: Gert Jan C. Veenstra, Radboud University Nijmegen, The Netherlands
Received October 28, 2011; Accepted April 10, 2012; Published May 14, 2012
Copyright:  2012 Scerbo et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by Ministe `re de l’Enseignement Supe ´rieur et de la Recherche PhD fellowships to PS, GVM and GL; by Fondation pour la
Recherche Me ´dicale (FRM: http://www.frm.org) PhD fellowships to PS and GVM; by an Association pour la Recherche sur le Cancer (ARC: http://www.recherche-
cancer.net) PhD fellowship to GL; by EU contract no. 018652 CRESCENDO; by Programme National de Recherche sur les Perturbateurs Endocriniens of Ministe `re
de L’Ecologie et du De ´veloppement Durable Contrat 2009 nu0007065 (PNRPE: http://www.pnrpe.fr/) and by l’Agence Nationale de la Recherche (ANR: http://
www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: coen@mnhn.fr
. These authors contributed equally to this work.
" These authors are  joint  senior  authors  on this work.
¤a Current address: Department for Evolutionary Biology, Max-Planck-Institute for Developmental Biology, Tu ¨bingen, Germany
¤b Current address: Department Of Dermatology, Institute for Regenerative Cure, University of California Davis, Sacramento, California, United States of America
Introduction
In vertebrates, early embryonic cells remain undifferentiated
prior to gastrulation. As such, they are not restricted to a
predetermined fate but can enter a number of differentiation
pathways leading to all the cell types of the adult organism.
This capacity is referred to as pluripotency. Examples of
pluripotent cells include cells of the inner cell mass and epiblast
of the mammalian blastocysts [1,2,3,4] and those of the animal
pole of Xenopus blastulae [5,6]. During gastrulation the gene
network that maintains the undifferentiated state is rewired and
embryonic cells gradually lose their initial high developmental
potential, which causes lineage restriction and allows the
progressive building of organs [7]. In this process, cell fate is
tightly controlled by signals that either promote the entry into
given differentiation paths, or restrict this capacity and maintain
cellular developmental potential.
Studies of pluripotency have uncovered key signals and
factors that promote maintenance of the uncommitted state or
lineage specification [8,9,10]. In mammals, these signals are
thought to converge on the POU5F1/SOX2/NANOG trium-
virate of transcription factors that constitutes the core network
controlling pluripotency [9,11,12]. Nanog, which encodes a
homeodomain-bearing transcription factor of the NKL class,
was first identified in mammals as being essential for early
embryonic development and germ-line establishment through its
capacity to restrain premature differentiation of embryonic stem
cells [3,13,14,15]. NANOG activity indeed protects undifferen-
tiated cells against the differentiation-inducing effects of
extracellular signals and transcriptional noise [15,16]. Though
Nanog was initially thought to be a mammal-specific gene,
orthologs have been characterized in most vertebrate species,
including birds [17,18], teleosts [19,20] and non-anuran
(urodele) amphibians [21,22]. Constitutive expression of a
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"   *modified axolotl Nanog ortholog was shown to sustain pluripo-
tency in mouse ES cells cultured in the absence of LIF
[18,20,21]; further, functional assays have shown that chick as
well as zebrafish Nanog orthologs could restore the capacity to
reprogram Nanog-deficient murine cells to fully pluripotent iPS
cells [23], suggesting that this factor controls developmental
potential across osteichtyes.In Xenopus, uncommitted embryonic
cells maintain high developmental potential until the onset of
gastrulation [5,6], similar to Nanog-expressing epiblastic cells in
amniote embryos [3,9,24]. However, much less is known about
the molecular mechanism that underlies this cellular property in
Xenopus. Interestingly, in all tetrapods, including Xenopus,
uncommitted embryonic cells express transcription factors of
the POU5F1 family [18,21,25,26,27]. In mammals, chick and
amphibians, POU5F1s maintain embryonic cells in an uncom-
mitted state, preventing their differentiation [18,25,28,29].
However, if most of the major players in the mammalian
pluripotency network are structurally conserved in the Xenopus
genome [20,30], so far no Nanog ortholog has been identified in
anuran amphibians [31]. Thus, either Nanog remains to be
characterized in anurans or other(s) factor(s) must maintain the
high developmental potential of uncommitted embryonic cells in
this taxon [5,6]. Here, we present evidence suggesting that this
function is carried out by ventx transcription factors in Xenopus.
Members of the VENTX family of NKL transcription factors
were first identified in Xenopus and owe their name (ventral
homeobox) to their ventral marginal zone expression domain in
Xenopus gastrulae [32,33]. They form a small multigenic family
organized in a compact cluster in most chordate genomes,
except mammals where either a single or no ventx ortholog is
found. Xenopus species possess at least 6 ventx paralogs, which
can be grouped in 3 subclasses: ventx1s, ventx2s and ventx3s.
There is longstanding agreement that all ventx1s and ventx2s
function in a similar fashion [34] and the less studied ventx3s
seem to follow this pattern as well [35,36]. All ventx factors are
known to act as transcriptional repressors and to be expressed
in roughly overlapping territories during early and late
development, ventx2s being more broadly expressed in spatial
and temporal terms [32,33,34,35]. More specifically, they are all
expressed in the animal hemisphere of blastulae and the ventral
side of early gastrulae, where they participate in the bmp4-
controlled gene network that acts in the establishment of dorso-
ventral patterning [33]. In this ‘‘ventral center’’, they antagonize
dorsalization induced by the Spemann organizer, opposing the
spread of the organizer in ventro-lateral domains by regional-
izing the expression of organizer-specific genes, such as gsc [37].
When overexpressed in Xenopus embryos they give rise to
ventralized phenotypes, characterized at tailbud stage by
anterior truncations, short and/or bent tails and absent or
defective axial structures such as notochord and floor plate
[32,33,34,38]. Conversely, expression of dominant-negative ventx
constructs leads to double axis formation [34], whereas ventxs
knock-down causes severe dorsalization, characterized by the
loss of caudal territories and increased neuralization of the
ectoderm [37]. Here, we propose a reinterpreted role for ventx
factors, as guardians of high developmental potential during
early Xenopus development. This conclusion is based on the key
observation that ventx factors repress differentiation towards
dorsal as well as ventral fates and that their knockdown can be
rescued by ectopic expression of the mouse pluripotency
regulator Nanog. We suggest that this crucial activity protects
the future ventral territories from premature commitment
towards dorsal fates in order to ensure proper spatio-temporal
patterning of the embryo.
Results
Ventx and Nanog Factors Share Common Properties
We set out to identify a putative Nanog ortholog in Xenopus. In
silico screening of sequence repositories resulted in the detection of
annotated or putative Nanog orthologs in all gnathostomes, except
Xenopus species. Degenerate PCR-based approaches were also
unsuccessful (data not shown and see Supporting Information
S1 for Extended Experimental Procedures). Moreover, the
synthenic region where Nanog orthologs are found in other
tetrapods, including axolotl, is conserved in Xenopus tropicalis albeit
split over two scaffolds in the current state of the genome assembly
(see ensembl scaffolds GL173371 and GL173015). These scaffolds
contain no Nanog-related sequence, strongly arguing that the
absence of Nanog from the Xenopus genus is due to secondary loss.
Others have recently reached a similar conclusion [20]. Therefore,
we tested the alternative hypothesis that other Xenopus transcrip-
tion factors might be capable of functionally replacing Nanog.
As Nanog belongs to the NKL subclass of homeodomain-
containing proteins, we focused on this group to identify putative
candidates. Phylogenetic reconstruction showed NKL families to
be monophyletic, except for NK4 and VENTX (Fig. S1A).
Surprisingly, the amphioxus Ventx orthologs [39] appear at the
base of the NANOG group, suggesting that VENTX and
NANOG families might be closely related (Fig. S1C). Further-
more, these families share multiple features that are unique among
NKLs. Notably, VENTX and NANOG are the only NKL families
to have been lost in specific vertebrate lineages: Nanog is absent in
the Xenopus genus whereas, inversely, rodents lack Ventx. Also,
VENTX and NANOG are the only NKL to have numerous
processed pseudogenes in the human genome (6 and 10
respectively) [40], which often correlates with expression in the
germline or its embryonic precursors, and is a proposed signature
of genes involved in the maintenance of pluripotency [41]. Finally,
VENTX and NANOG have long branches when compared to
other NKL families (e.g. NK1 or LBX, see Fig. S1), indicating
that the homeodomains from these two families are less conserved
among vertebrates than those from other NKLs (see also Table
S1). These shared features make Xenopus ventxs good candidates for
serving Nanog-like functions.
In line with this hypothesis, mammalian Nanog and Xenopus ventx
genes encode transcriptional repressors [34,42,43] and share
striking functional similarities (summarized in Table S2). First,
the orthologs of many genes regulated by ventxs in Xenopus are
regulated by NANOG in mammals; second, Nanog and ventxs are
regulated by the same signalling pathways and transcription
factors; third, ventxs and NANOG interact with orthologous
proteins. One of the most significant parallels is that, in Xenopus
and teleosts, endogenous ventx and pou5f1 transcription factors
interact physically and genetically during early development
[44,45,46], as do mammalian NANOG and POU5F1 [9].
Mouse Nanog and ventx1/2 Overexpression have Similar
Effects
These extensive similarities prompted us to compare the effects
of overexpression of mouse Nanog (mNanog) to combined Xenopus
ventx1.2 [32] and ventx2.1-b [47] (referred to as ventx1/2 from now
on) overexpression on Xenopus embryonic development. The
relevant mRNAs were dorsally injected at the 4-cell stage (NF3
[48]), using previously described doses for ventx1/2 (0.5 ng per
blastomere [34]) and half the lethal dose for mNanog (0.6 ng per
blastomere, see Fig. S2). As expected [34], ventx1/2 overexpres-
sion led at tailbud stage (NF28) to severely ventralized phenotypes
with truncated anterior structures (Fig. 1A). Remarkably, mNanog
Ventx Factors Control Developmental Potential
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trance (Fig. 1, A and B, and Fig. S3C). In contrast,
overexpression of the medaka ortholog OlNanog led to phenotypes
clearly distinct from those obtained with mNanog, no ventralization
being observed at any of the doses assayed, with all embryos
displaying clear head features (Fig. S3A).
We next checked if ventx1/2 and mNanog dorsal overexpression
had similar impacts on gene expression. As previously reported,
ventx1/2 overexpression strongly repressed the transcription of the
dorsal organizer markers gsc [34] and hhex [49] at gastrula stage
(NF10.5) and the blood island marker hba4 (also known as alpha-T4
globin) [50] at stage NF28 (Fig. 1C and Fig. S3E). Remarkably,
similar effects were observed in embryos injected with mNanog
(Fig. 1C), while OlNanog injection did not lead to repression of gsc
at gastrula stage (Fig. S3E), or hba4 at NF28 (data not shown).
The results support the hypothesis that mammalian Nanog and
Xenopus ventx1/2 share functional properties, and are coherent with
the observation that OlNanog seems to share only limited functional
similarities with its mammalians orthologs [19].
ventx1/2 and mNanog Overexpression Down-regulate
Specification Markers for all Germ Layers and Embryonic
Territories
We next assessed whether the ventralizing effects of ventx1/2
and mNanog overexpression result from similar impacts on
developmental gene expression. msx1 codes for another ventraliz-
ing NKL transcription factor and was used as a control at a dose
(600 pg/embryo) known to efficiently ventralize embryos [51,52].
Radial injections of ventx1/2, mNanog or msx1 mRNAs in NF3-
embryos were performed and expression levels of ectodermal,
mesodermal, and endodermal markers were analyzed by RT Q-
Figure 1. mNanog and ventx1/2 overexpression cause similar effects in Xenopus embryos. (A) Four-cell stage embryos (NF3) were injected
in both dorsal blastomeres, with a 1:3 mix of ventx1.2 and ventx2.1-b mRNAs (ventx1/2; 0.5 ng per blastomere), with mouse Nanog mRNA (mNanog;
0.15 ng/blastomere), or with water for control. Representative phenotypes observed at tailbud stage (NF28) are shown (lateral views, anterior to the
left, dorsal to the top). (B) Percentages of observed phenotypes in three independent experiments for mock (n=14), ventx1/2 (n=31) and mNanog
(n=36) mRNAs injections. (C) Embryos injected as in (A) were collected at early gastrulae (NF10.5; whole embryos: ventral view, dorsal side to the top;
hemisected embryos: lateral view, dorsal to the left, animal side to the top) and tailbud (NF28; ventral view, anterior to the left) stages and processed
for whole-mount in situ hybridization (WISH) with a gsc or hhex probe, or with hba4 (black arrowheads) and egr2 (white arrowheads), respectively. The
number of embryos showing staining similar to the one photographed over the total number of embryos assayed is indicated.
doi:10.1371/journal.pone.0036855.g001
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repressed most markers analysed, which was not the case for
msx1. More specifically, all three factors had comparable anti-
dorsalizing activities, as revealed by the robust repression of the
organizer markers gsc, hhex, and not. Remarkably, they also
repressed in a similar fashion the ventral mesoderm marker bmp4
and the early ectoderm markers lim5 and foxi1a. In contrast,
other genes involved in epidermis (tfap2), axial (t/bra) and
paraxial mesoderm (myf5) commitment were significantly down-
regulated by ventx1/2 and mNanog but not msx1. Overall, msx1,
ventx1/2 and mNanog overexpression repress early markers of
various cell fates in all germ layers, but marked differences
appear.
We also assessed the impact of ventx1/2 loss of function on the
same markers. For this, morpholino oligonucleotides directed
against ventx1 and ventx2 pseudoalleles (ventx1/2 MOs) [37] or
control MO were injected radially in NF3-embryos and gene
expression was analyzed at stage NF10.5. We observed that
ventx1/2 knock-down led to significant overexpression of a number
of genes repressed by ventx1/2 (not, lim5, bmp4). This inverse
regulation did not quite reach significance for all markers, perhaps
reflecting the redundant activity of ventx3s. However, we noted that
the mean level of gsc RNA induction in our experiment is within
the range reported elsewhere [37]. Similarly, mean levels of eomes,
hhex, foxi1a, sox17 and mixer were raised, though significance was
not reached. Unexpectedly, epidermal keratin (k81a1) was
repressed both upon ventx1/2 knock-down, and ventx1/2 or mNanog
overexpression. This might be explained by the fact that ventx1/2-
deficient ectodermal cells tend to become neural, as suggested by
sox2 up-regulation. A similar line of reasoning can be applied to
the ventral marker wnt8.
Altogether, these data suggest that msx1, ventx1/2 and mNanog
may regulate differentially early developmental networks, though
causing similar ventralized phenotypes.
ventx1/2 and mNanog Repress Fate Commitment
To evaluate the above hypothesis, we focused on epidermal
differentiation, which is known to require Msx1 function [52]. We
injected msx1, ventx1/2 or mNanog mRNAs either unilaterally, in
one blastomere of 2-cell stage embryos (NF2, Fig. 3A) or at the
16-cell stage (NF5, Fig. 3B) in one AB4 blastomere fated to give
rise only to epidermis. Both mNanog and ventx1/2 repressed
expression of the committed ectoderm marker k81a1 in compa-
rable fashion at NF10.5, whereas msx1 had no effect on epidermal
differentiation. This result indicates that ventx1/2, unlike msx1,d o
not favour, but rather impede epidermal differentiation.
To further assess if ventx1/2 restrain commitment in Xenopus, the
‘‘ventralizing’’ activity of msx1 was tested in the presence or excess
of ventx1/2. Thus, msx1 and ventx1/2 mRNAs were injected
separately or co-injected radially at the same concentration in one
blastomere in NF2-embryos. Expression of the mesodermal
marker myf5 was then assessed by whole-mount in situ hybridiza-
tion (WISH) at stage NF10.5 (Fig. 3C), as it is known that msx1
positively regulates paraxial mesoderm differentiation [53]. In
control embryos, myf5 is expressed in two dorso-lateral patches
around the organizer. As expected, myf5 expression expanded into
the organizer in the presence of msx1. Conversely, myf5 was
repressed in the ventx1/2-injected side, in agreement with its
previously described activity on paraxial mesoderm [54]. Strik-
ingly, joint overexpression of ventx1/2 and msx1 also resulted in
myf5 repression, demonstrating that ventx1/2 are able to antagonize
msx1 activity during mesoderm commitment. Similar results were
obtained using half as much ventx1/2 mRNAs (data not shown),
suggesting that the difference of activity between ventx1/2 and msx1
is qualitative rather than quantitative.
The above data suggest that commitment into specific lineages,
even of ventral origin, is not possible in the presence of high levels
of ventx activity.
ventx1/2 Knockdown Represses Pluripotency Genes and
Induces Premature Commitment
As pro-differentiation genes were up-regulated in ventx1/2
morphants (Fig. 2), we hypothesized that these factors are
involved in the temporal restriction of commitment in early
embryos. In line with this hypothesis, we detected by RT-QPCR
ventx1.2 and ventx2.1-b messengers in ovaries, unfertilized eggs and
embryos from stages NF1 to NF10.5 (data not shown) and
ventx2.1-a is known to be maternally expressed [55]. Furthermore,
we found that ventx2.1-b is present in both animal and vegetal
halves of 8-cell embryos (NF4, Fig. S4).
To test whether ventx1/2 are functionally required to restrict
cellular commitment during early Xenopus development, we next
performed RT-QPCR to monitor kinetics of expression following
ventx1/2 knockdown (Fig. 4A). Time-course experiments revealed
that in ventx1/2 morphant embryos, expression levels of early
dorsal mesendoderm (siamois, gsc, hhex), ventral mesendoderm
(wnt8), pan-endodermal (mixer) and ventral ectoderm (tfap2a, k81a1)
markers are higher at the 4000-cell stage when activation of
zygotic transcription or ‘‘mid-blastula transition’’ (MBT) occurs.
Remarkably, stronger expression was also observed at pre-MBT
for xnr5, a nodal-related factor that participates in primary germ
layer induction at these stages and pre-patterns the dorsal side of
the embryo [56]. Overall, the expression profiles seem to be shifted
to earlier time-points and to reach higher levels in ventx1/2
morphant embryos. These results suggest that in morphant
embryos, cells are no longer protected against premature
commitment. Interestingly, embryos in which the POU5F1 family
member oct91 is knocked-down also fail to maintain a multipotent
uncommitted cell population [25,29]. We thus tested whether up-
regulation of pro-differentiation markers in ventx1/2 LOF is
accompanied by down-regulation of this marker of the uncom-
mitted state. The expression of oct91 was significantly down-
regulated after ventx1/2 knockdown, as assessed by RT-Q-PCR
and WISH (Fig. 4, B and C). However, no significant up-
regulation of oct91 was seen following ventx1/2 overexpression.
We conclude that ventx1/2 activity is necessary, but not
sufficient, to maintain the uncommitted status of embryonic cells
during Xenopus early development.
Ectopic Expression of Mouse Nanog but not msx1
Rescues ventx1/2 Morphant Embryos
Based on the above data, we tested the ability of mNanog to
rescue development of ventx1/2 knock-downed embryos. MOs
directed against ventx1/2 [37] or control MO were first injected
radially in each blastomere at the 2-cell stage (NF2), followed by
radial injections in all blastomeres at stage NF3 of either mNanog or
msx1 mRNAs (Fig. 5A). Injections of control MO+mNanog and
control MO+msx1 led to a high proportion of ventralized embryos
(Fig. 5, B and C, about 80% and 60% respectively). As described
[37], ventx1/2 MOs injection caused dorsalization defects in 80%
of embryos, whereas control injections (control MO+water)
yielded 90% of normal embryos. Quite remarkably, the addition
of mNanog mRNA to ventx1/2 MOs produced 50% of embryos with
normal morphology. Antero-posterior (Fig. 5D) and dorso-ventral
axes (Fig. 5E) were correctly restored in such embryos, as revealed
by whole mount in situ hybridization for markers of notochord
Ventx Factors Control Developmental Potential
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and egr2, also known as optx2 and krox-20 respectively). In contrast,
msx1 overexpression failed to restore a normal morphology in
ventx1/2 morphant embryos. In this condition, about 60% of
embryos remained dorsalized and about 40% became ventralized,
confirming that msx1 ventralizes embryos through mechanisms
distinct from the ones induced by ventx1/2 and mNanog (Fig. 5E).
Altogether, these results demonstrate that mNanog is able to
substitute for ventx1/2 in Xenopus development and that this effect is
specific.
Discussion
In this study, we report a number of properties of ventx1/2 in the
Xenopus embryo that call for a reassessment of their biological role.
Although ventx1/2 and msx1 are thought to be ventralizing
Figure 2. mNanog, ventx1/2, and msx1 cause distinct effects on early patterning gene expression. For gain-of-function experiments, NF3-
embryos were injected radially in all blastomeres with water, msx1 mRNA (0.3 ng/blastomere, red), mNanog mRNA (0.15 ng/blastomere, blue) or
ventx1/2 mRNAs (0.5 ng/blastomere, green); For loss-of-function experiments, NF-2 embryos were injected twice radially in both blastomeres with
control MO (30 ng/blastomere), or a 1:1 mix of ventx1/2 MOs (30 ng/blastomere, purple). All embryos were collected at stage NF10.5 and processed
for RT-QPCRs. Ectodermal, mesodermal and endodermal markers were assayed (each quantification was performed at least 3 times independently).
For all RT-QPCR, graphs represent means of the fold-change calculated versus the appropriate control (fldx injected embryos in cases of
overexpression and control MO for ventx1/2 knock-down) +/2 s.e.m, and significance was assessed using paired t-test (*p#0.05, **p#0.005,
***p#0.0005).
doi:10.1371/journal.pone.0036855.g002
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dorsal but not ventral markers [52,53 and our results], whereas
ventx1/2 suppress both dorsal and ventral markers in mesoderm
and in epidermis [50,55, and our results]. Consequently, ventx1/2
cannot be considered bona fide ventralizing factors. Instead, we
propose that ventx1/2 are guardians of developmental potential in
the early embryo, a function that is necessary to achieve
proportioned and progressive building of the body.
Supporting this view, we found that, in gastrulae, increased
ventx1/2 activity represses the expression of transcription factors
involved in early cell commitment in all germ layers, including a
significant down-regulation of hhex, gsc, not, bmp4, t/bra, wnt8, lim5,
foxi1a, tfap2a, and myf5 (Fig. 1 and Fig. 2). Conversely,
knockdown of ventx1/2 results in the significant up regulation of
the differentiation markers sox2, lim5, bmp4, not, eomes (Fig. 2).
Further, we show that ventx1/2 are necessary to maintain normal
expression levels of the well-identified pluripotency effector oct91
during gastrulation (Fig. 4, B and C). Thus, ventx1/2 appear to be
involved in an active mechanism protecting blastula/gastrula cells
from the pro-differentiation cues that establish germ layers and
pattern the embryonic axis. The earliest role of ventx1/2 would
therefore not be the establishment of ventral identity, but rather to
prevent premature commitment, similar to Xenopus pou5f1s
[25,29,44,57,58]. In line with this hypothesis, it is important to
Figure 3. ventx1/2 overexpression prevents multiple lineage commitment. (A) NF2-embryos were injected twice in one blastomere, either
with msx1 mRNAs (0.6 ng/blastomere), ventx1/2 mRNAs (1 ng/blastomere), mNanog mRNA (0,3 ng/blastomere), or with water for control; fldx was
used as a lineage tracer. WISH with a k81a1 probe were performed at stage NF10.5 (left panels, animal views, dorsal side to the top). The progeny of
the injected blastomere was revealed by fluorescence; white arrows indicate the injected side (right panels). (B) Sixteen-cell stage embryos (NF5) were
injected in one AB4 blastomere with msx1 mRNA (0.15 ng), ventx1/2 mRNAs (0.5 ng), mNanog mRNA (0.15 ng), or water, collected at stage NF10.5
and processed for WISH with a k81a1 probe (animal views). Black stripped lines mark the border between injected and uninjected domains. (C) NF2-
embryos were injected twice in one blastomere with msx1 mRNA (5 ng/blastomere), ventx1/2 mRNAs (5 ng/blastomere), ventx1/2+msx1 mRNAs (5 ng
+5 ng/blastomere), or with water. WISH with a myf5 probe were performed at stage NF10.5; black arrowheads point to myf5-expressing territories
(left panels, ventral views, dorsal side to the top). The progeny of the injected blastomere was revealed by fldx fluorescence; white arrows point to the
injected side (right panels).
doi:10.1371/journal.pone.0036855.g003
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and ventral mesoderm) remain multipotent until late gastrulation
[59,60], ii) that active clearance of ventx proteins coincides with
loss of multipotency at mid-gastrula stages [61], iii) that post-
gastrula ventx2.1 expression territories coincide with stem cell-
containing niches such as the dorsal ciliary margin of the eye [47]
and the tailbud [62] and iv) that ventx2.1 is re-expressed together
with oct91 in Xenopus somatic cells reprogrammed to an iPS-like
state in vivo [63].
Our work thus highlights the role of ventx1/2 in linking cell
commitment to embryonic axis patterning and agrees with
experimental and theoretical works suggesting that the dorso-
ventral genetic system, to which ventx1/2 belong, functions
primarily as a regulator of the timing of cell commitment [64].
Indeed, according to our hypothesis, ventx1/2 would maintain
early embryonic cells in an undetermined state and limit their
competence to respond to differentiation-inducing signals, as
NANOG does to maintain pluripotency in mammalian embryos
[16,65]. The ability of mNanog to rescue the ventx1/2 morphant
phenotype in Xenopus embryos strongly supports this contention
(Fig. 5). In our re-interpretation of their role, ventx1/2 factors, as
regulators of timing of commitment, control the progressive
allocation of embryonic cells to the developing body axis. Loss of
ventx1/2 allows cellular commitment and most cells precociously
adopt dorsal and anterior positional identities, similar to the cells
that first become negative for ventx1/2 in normal embryos.
Consequently, the pool of cells available to build posterior
territories is depleted, resulting in minute trunk-tail structures
[37]. Conversely, ectopic ventx1/2 activity represses early
commitment factors and thus causes dorso-anterior truncations
[34]. As such embryos do develop posterior structures, we surmise
that the uncommitted cellular state is only transient, in agreement
with the reported loss of cellular competence at the end of
gastrulation in normal embryos. Importantly, our data supports a
role for ventx1/2 in restricting cell commitment starting at pre-
MBT stages. Recent work underlines the importance of Wnt/bcat
and Nodal signalling in priming cells for induction of mesendo-
derm and establishment of dorsal identity as early as the 1000-cell
stage, well before MBT [56,66]. Here, we show that knockdown of
ventx1/2 results in premature and/or increased expression of a
number of developmental genes including the nodal-related xnr5,a s
well as the dorsal organizer genes hhex, gsc and siamois at or before
the MBT (Fig. 4A). Taken together, the evidence presented here
supports the concept that control of developmental potential is a
strategy that ensures correct germ layer formation and body
patterning, common to all gnathostomes [25].
Our proposed role of ventx1/2 in the control of cellular
differentiation echoes earlier studies performed by W. Kno ¨chel
and collaborators [44]. Interestingly, these researchers recently
tested the hypothesis that Xenopus ventxs could be functional
Figure 4. ventx1/2 activity is necessary to maintain an uncommitted cell population in early gastrulae. (A) NF2-embryos were injected
radially twice in both blastomeres with control MO (30 ng/blastomere), or a 1:1 mix of ventx1/2 MOs (30 ng/blastomere). Variations of gene
expression at 516-, 1000-, 2000-, 4000-cell and NF10.5 stages were assessed by RT-QPCR as in Fig. 2. Dorsal (siamois, gsc, hhex), and ventral (wnt8)
mesendoderm, endoderm (xnr5, mixer) and ectoderm (tfap2a, k81a1) markers were monitored. Kinetic graphs represent means of fold-change
relative to NF10.5 controls +/2 s.e.m, and significance was assessed using paired t-test (*p#0.05, **p#0.005, ***p#0.0005), and undetectable levels
of transcript noted as W.( B) Animal injections were performed twice in a single blastomere NF2-embryos, using MO conditions described in (A); fldx
was used as a lineage tracer. WISH with an oct91 probe (left panel) were performed at stage NF10.5 and the progeny of the injected blastomere was
revealed by fluorescence (right panel). Embryos are positioned with the animal side upwards; white arrows indicate the injected side. (C) Injections
were performed using mRNA and MO conditions described in Fig. 2. All embryos were collected at stage NF10.5 and processed for RT-QPCRs using
the pluripotency marker oct91. Data and graphs are presented as in Fig. 2.
doi:10.1371/journal.pone.0036855.g004
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with ours, as they did not observe rescue of morphant ventx1/2
embryos by mNanog. The reason for this discrepancy is unclear but
may possibly reflect differences in experimental setup. The positive
evidence of rescue of ventx1/2 knockdown by mNanog in this paper
supports the view that ventx and Nanog genes are related and that
Xenopus ventx1/2 and mammalian Nanog serve comparable devel-
opmental functions through the regulation of overlapping tran-
scription programs (see Table S2). Indeed, while genetic
responses induced by mNanog and ventx1/2 overexpression do not
perfectly match at early stages (NF10.5, Fig. 2), these differences
seem to be buffered by the regulation networks at work during
germ layer specification and embryonic patterning, up to the point
that mNanog is able to substitute for ventx1/2 to generate
morphologically normal larvae (Fig. 5).
Other amphibians possess Nanog orthologs [21,22], raising the
question of whether the role of ventxs in developmental potential
maintenance is ancestral, or is an innovation specific to Xenopus.
Functional data strongly support the ancestrality of ventxs
involvement in this process, since teleost and Xenopus ventxs serve
the same function during development [45,67,68]. Unfortunately,
data concerning amniote Ventx genes is scarce, probably because
they are absent from the genome of the mouse, the main
experimental model in this taxon. Partial functional redundancy
between Ventx and Nanog might explain the loss of the former in
rodents and of the latter in Xenopus. Some indirect evidence
supports this notion in mammals. The human ventx ortholog
(VENTX) located next to the stem-cell marker UTF-1, shares
features with its counterparts in Xenopus and fish [69]. Both human
and Xenopus ventx orthologs [70] are direct targets of POU5F1
transcription factors [44,71,72], and human VENTX displays
ventralizing activity in zebrafish embryos [69]. As mentioned
earlier, VENTX retropseudogenes are unusually frequent in the
human genome [40], a feature that is proposed to be a specific
signature of genes involved in pluripotency maintenance such as
POU5F1 and NANOG [41]. In line with this idea, VENTX is co-
expressed with NANOG and POU5F1 in pluripotent-embryonal
carcinomas [73], a subtype of human male germ cell tumours
constituted of cells highly similar to early zygotic and ES cells [74],
and these three genes are strongly down-regulated when tumour
cell differentiation is forced in vitro [73]. Furthermore, a genome-
wide RNA interference screen has shown that in human ES cells,
VENTX or NANOG knockdown results in reduced expression of a
POU5F1-GFP reporter construct in a comparable way (see
Supplemental Information in [75]). Finally, VENTX expression is
under the control of the POU5F1/SOX2/NANOG triumvirate,
(http://biit.cs.ut.ee/escd/index.cgi?gene=ventx [72,76]) suggest-
Figure 5. mNanog expression rescues specifically ventx1/2 morphant embryos. (A) Two-cell stage embryos (NF2) were first injected radially
twice with control MO (30 ng/blastomere), or a 1:1 mix of ventx1 and ventx2 MOs (ventx1/2 MOs; 30 ng/blastomere), and subsequently injected
radially at NF3 in all blastomeres with mNanog mRNA (0.15 ng/blastomere), msx1 mRNA (0.15 ng/blastomere), or with water. (B) Range of
phenotypes observed in rescue of ventx1/2 knockdown experiment. (C) Percentages observed for each phenotypic category in three independent
replicates of the rescue experiment. The combined injections performed are indicated at the bottom of the graph, and the number of injected
embryos for each condition is indicated on the top of each bar. NF28 embryos were processed for WISH with six6, egr2 and hoxb9 (D), or six6, shh and
hba4 (E) probes (anterior to the left, dorsal to the top).
doi:10.1371/journal.pone.0036855.g005
Ventx Factors Control Developmental Potential
PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e36855ing that it may be part of the human pluripotency-regulating
network [72,76].
In conclusion, our data strongly support the concept that ventx1/
2 act as guardians of high developmental potential during Xenopus
early development. We propose that this role of Ventx genes is
ancestral and conserved in gnathostomes, a question for future
research with high biomedical relevance.
Materials and Methods
Ethics Statement
The care and treatment of animals used in this study were in
accordance with institutional and national guidelines (Commission
de Ge ´nie Ge ´ne ´tique, ‘‘Direction De ´partementale des Services
Ve ´te ´rinaires’’, European Union Directive 2010/63, registered as
No. 4654 for the agreement decision, and as No. B 75-05-01 for
the vertebrate living animals experimentation; this commission
specifically approved this study).
In Silico Screening
Homeodomain sequences from all reported Nanog genes were
retrieved from public repositories (http://www.ncbi.nlm.gov/;
http://www.ensembl.org/) and used as queries to perform several
rounds of TBLASTN screening on the Xenopus tropicalis genome
assembly (http://genome.jgi-psf.org/Xentr4/Xentr4.home.html),
as well as on available expressed sequence tags and cDNA
sequences from Xenopus tropicalis and Xenopus laevis (http://www.
ncbi.nlm.gov/). Control searches using the same queries to screen
published gnathostome genomes allowed the identification of at
least one likely candidate in each case.
Reverse Transcriptase - PCR Screening
Total RNAs were extracted from Xenopus laevis ovaries,
unfertilized and fertilized eggs (NF1), blastulae (NF8) and early
gastrulae (NF10.5). The RT-PCR protocol and primers used are
detailed in supporting information.
Phylogenetic and Conservation Analyses
The methodologies used to perform molecular phylogenetic and
conservation analyses of the NKL family are detailed in supporting
information.
Xenopus Embryo Manipulations
Sacrifices and animal studies were conducted according to the
principles and procedures described in Guidelines for Care and
Use of Experimental Animals. Xenopus laevis were obtained by in
vitro fertilization and staged according to Nieuwkoop and Faber
[48] and cultured according to Slack et al. [77]. Embryos were
injected with RNAs and/or morpholino oligonucleotides (MOs) as
described in the relevant figure legends. We determined that the
lethal dose for mNanog is 1 ng per embryo (data not shown).
Dextran fluorescein (fldx; Molecular Probes) was used as a lineage
label. In order to rule out possible interference of MOs mixed with
mRNAs before injection, we performed rescue assays through
injections of MOs at the 2-cell stage (NF2), followed by mRNAs
injections at the 4-cell stage (NF3). All injections were performed
at least three times to assess reproducibility.
In vitro Translation and Morpholino Oligonucleotides
Synthetic capped mRNAs were transcribed with the mMessage
mMachine SP6 kit (Ambion) using the following templates:
pCS2+-Vent1 and pCS2+-Xbr1b, both linearised with NotI (gifts
of N. Papalopulu, University of Manchester, UK and collectively
referred to as ventx1/2 in this work); pSP64T-xMsx1, linearised
with EcoRI; pCS2+OlNanog, linearised with SacII (Gift of JL.
Mullor, Centro de Investigacio ´n Prı ´ncipe Felipe, Valencia, Spain).
To express mNanog, the ORF of a commercial clone (Geneservice)
was PCR amplified and cloned into pCS2+, linearised with NotI
and transcribed with mMESSAGE mMACHINE SP6 Kit
(Ambion). Previously described morpholino oligonucleotides
(MOs) directed against ventx1 and ventx2 pseudoalleles [37] were
obtained from GeneTools.
Whole Mount in situ Hybridization
Injected embryos were processed for whole-mount in situ
hybridization (WISH) with digoxigenin-labelled probes (Roche)
using standard procedures and staining was done with BM purple
(Roche). Embryos were bleached with hydrogen peroxide 4%
(Carlo Erba Reagenti) and photographed with a MZ16F binocular
(Leica).
Real-time Quantitative PCR and Statistical Analyses
For real-time quantitative PCR (RT-QPCR) total RNAs were
extracted from 10 post-MBT (Figs. 2 and 4C) or 5 pre-MBT
(Fig. 4A) embryos using RNeasy Plus Mini kit (Qiagen) and
reverse transcribed using Superscript II reverse transcriptase
(Invitrogen). Independent biological replicates were collected and
RT-QPCR reactions were performed in duplicate for each sample
using Power SYBRH master mix on a 7300 Real-Time PCR
System (Applied Biosystems), following manufacturer recommen-
dations. Primers (MWG Biotech) were described in previous
publications or designed using Primer Express Software (Applied
Biosystems), the relevant sequences and references are listed in
Table S3. Primers for the housekeeping gene DNA elongation factor
type 1 a (ef1a1)o rornithine decarboxylase 1 (odc1) were used as loading
control for samples collected post-MBT (Figs. 2 and 4C) and pre-
MBT (Fig. 4A), respectively. Ct data were collected using 7300
system software (Applied Biosystem) and analyzed using Excel
(Microsoft). For Figs. 2 and 4C, the Ct for each technical
duplicate was averaged and normalized against ef1a1. Variations
of expression were quantified using the DDCts method, using the
control condition as reference for each experimental replicate and
fold changes were computed as 2
DDCt. Data from independent
experiments were averaged, plotted and significance was assessed
(two-way paired Student’s t-test) using Prism 5.03 (GraphPad). For
Fig. 4A, the Ct were normalized against odc1. Levels of expression
were quantified using the DCts method averaged, plotted and
significance was assessed (two-way paired Student’s t-test) using
Prism 5.03 (GraphPad).
Supporting Information
Figure S1 Phylogenic reconstruction of the NKL group
homeodomains relationships using Maximum Likeli-
hood. (A) Global view of an unrooted maximum likelihood tree
obtained with the homeodomain sequences of all known NKL
members found in the genomes of the fly, amphioxus and a
representative selection of vertebrates (see Supporting Information
for Extended Experimental Procedures). NKL families are
highlighted in different shades of grey except for NANOG (red)
and VENTX (blue). Relationships between NKL families remain
elusive; however all are monophyletic and well supported by
bootstrap analysis with three exceptions: the NK4 (paraphyletic)
VENTX (polyphyletic) and NANOG (monophyletic, but poorly
supported, bootstrap: 54,4%). (B) Close-up of the region of the tree
where most VENTX orthologs are found. (C) Close-up of the
region of the tree containing the monophyletic NANOG group.
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toma floridae and VENT2 Branchiostoma floridae) are found at the root
of the NANOG subtree. However, this association is not supported
by bootstrap analysis (bootstrap: 18,7%) and the interpretation of
amphioxus VENTXs as NANOG orthologs is at odds with the
literature [39]. Both NANOG and the main VENTX group have
longer branches than typical NKL-class members (e.g. NK1 and
LBX groups on panels B and C, see also Table S1).
(TIF)
Figure S2 Determination of lethal doses of mNanog and
OlNanog. NF3-embryos were injected radially in all blastomeres,
with water, mNanog mRNA or OlNanog mRNA at multiples doses and
embryonic lethality was assessed at late blastula (NF9) and early
tadpole (NF31). The doses indicated correspond to the total amount of
mRNA injected per embryo. (A-C) Representative NF9 embryos
observed in the indicated conditions (top panels), an arrow points to
the embryos shown at greater magnification (bottom panels). The
number of embryos injected is indicated. (D-E) Percentage of lethality
observed at NF9 and NF31 after mNanog and OlNanog injection,
respectively. The numbers of dead and living embryos observed at
both time points is given under the graphs. Note that a dose of 1,2 ng
of mNanog results in 100% embryonic lethality at NF9, while 0,6 ng
(half the lethal dose) had no toxic effect; hence this condition was
retained for further study. Conversely, OlNanog overexpression led to
increased lethality beyond the 2 ng injection condition of OlNanog
RNA (dotted line). Embryo death arose from 5 ng injected embryos,
and about 40% or 100% lethality was observed at NF31 for the 5 ng
or the 10 ng conditions respectively. Hence the condition with 1,2 ng
injected embryos was retained for further study.
(TIF)
Figure S3 OlNanog overexpression leads to phenotypes
that strongly differ from those observed upon mNanog
or ventx1/2 overexpression. (A) NF3 embryos were injected
radially with OlNanog mRNA (0.6 ng, 1.2 ng, 2 ng and 5 ng./
embryo), or with water for control. Representative phenotypes
observed at early tadpole stage (NF31) are shown (lateral views,
anterior to the left, dorsal to the top). (B) Percentages of observed
phenotypes for the different OlNanog mRNAs doses assayed. Across
the whole range of concentration used, the phenotypes obtained in
OlNanog-injected embryos strongly differed from those resulting
from mNanog overexpression (C and D). No cues of ventralization
were observed as seen with mNanog-injected embryos (see black
arrowheads in C), the embryos retaining distinguishable head
structures. The main effect was a shortened axis, resulting from
defects in blastopore closure (see white arrowheads in A).
(TIF)
Figure S4 ventx2.1 mRNAs are present in animal and
vegetal cells of 8-cell stage Xenopus embryos. (A) 8-cell
stage Xenopus embryos were separated in animal and vegetal halves,
which were separately processed for RT-QPCR. (A) ventx2.1 (green)
mRNA abundance in the two territories was estimated relative to
the odc loading control marker, while vegt (purple) was used as a
positive control. (B) As expected, we observed that vegt mRNA is
almost exclusively localised in the vegetal blastomeres, while in
contrast ventx2.1 mRNA is predominantly found in animal
blastomeres but is also significantly present in vegetal blastomeres.
(TIF)
Table S1 Nanog and Ventx homeodomains are less
conserved than other NKL families. For each NKL family
conserved among vertebrates (1
st column) the homeodomains
(HDs) of all Homo sapiens, Xenopus tropicalis, Danio rerio and Takifugu
rubripes paralogs were retrieved (see Supporting Information S1 for
Extended Experimental Procedures). When a given paralog was
unknown in a given species but present in a closely related one,
this alternate sequence was used instead. More specifically: (£)
EMX1 being unknown in Takifugu rubripes, the Tetraodon nigroviridis
sequence was used; (&) NANOG being unknown in Xenopus species
the Ambystoma mexicanum sequence was used. For each group of
orthologs, the percentage of identity along the HD of the four
relevant sequences was computed. For families with multiple
paralogs, only the least conserved are shown here (2
nd column).
The consensus sequence and percentage of identity thus obtained
are indicated (3
rd and 4
th columns). The VENTX and NANOG
families (in bold) present the lowest sequence identity in the HD,
and are the only NKL families for which numerous processed
pseudogenes are found in the human genome (5
th column) [40,78].
This similarity extends to functional properties (see Table S2).
(TIF)
Table S2 Mammalian Nanog and Xenopus ventxs share
striking functional similarities. Mammalian Nanog (left) and
Xenopus ventx1/2 (right) are ‘‘regulated by’’ (A and B), ‘‘regulate’’
(C) and ‘‘interact’’ (D) with homologous pathways, transcription
factors, genes and proteins, respectively. Most of these factors are
known to regulate pluripotency and/or cell commitment and
differentiation in mammals (indicated by P/C), while their
counterparts in frog are known to be involved in dorso/ventral
patterning during embryogenesis (indicated by D/V). References
78–110 are listed as Supplemental References in Supporting
Information.
(TIF)
Table S3 Primer pairs used for RT-QPCR experiments
in this study. For each primer pair, the forward and reverse
sequences are listed, as well as the original publications (references
111–125 are listed as Supplemental References in Supporting
Information).
(TIF)
Supporting Information S1 The Supporting Information
file contains Extended Experimental Procedures and
Supplemental References.
(DOC)
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